Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/CO/Grand Junction

Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Grand Junction, CO

Q: How much do paid clinical trials in Grand Junction pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Q: How do I join a study in Grand Junction, CO?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

Q: Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

Q: What is the difference between a research center and a hospital study in Grand Junction?

Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Q: Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Grand Junction typically complete one or two studies per year.

Studies commonly pay $75 to $4,500 per completed study

51 clinical trials are currently recruiting participants within 30 miles of Grand Junction. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

51studies recruiting

2+research centers nearby

2condition categories

Live from the NIH registry

Studies recruiting near Grand Junction right now

Top 25 of 51 recruiting studies, sorted by proximity — each links to its official registry page

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms Phase 3 Interventional 2,400 participants sought

Intermountain Health St. Mary's Regional Hospital ( Site 0054) — Grand Junction, Colorado (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06966700)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis, Multiple Sclerosis N/A Observational 2,000 participants sought

TG Therapeutics Investigational Trial Site — Grand Junction, Colorado (1.9 mi) · Sponsor: TG Therapeutics, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06433752)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought

Grand Valley Oncology — Grand Junction, Colorado (1.9 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05256225)

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Breast Neoplasms, Carcinoma, Ductal, Breast N/A Interventional 725 participants sought

Intermountain Health — Grand Junction, Colorado (1.9 mi) · Sponsor: Natera, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07214532)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05879926)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04269902)

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

Advanced Breast Cancer Phase 3 Interventional 788 participants sought

Research Site — Grand Junction, Colorado (1.9 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06380751)

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant Phase 3 Interventional 800 participants sought

Grand Valley Oncology — Grand Junction, Colorado (1.9 mi) · Sponsor: Janssen Research & Development, LLC

See eligibility & contact on ClinicalTrials.gov (NCT07225946)

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Persistent Corneal Epithelial Defect Phase 2 Interventional 84 participants sought

Glaukos Investigative Site — Grand Junction, Colorado (1.9 mi) · Sponsor: Glaukos Corporation

See eligibility & contact on ClinicalTrials.gov (NCT05966493)

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Breast Neoplasms Phase 3 Interventional 1,000 participants sought

St. Marys Hospital and Regional Medical Center-SCL Health Cancer Centers of Colorado ( Site 0021) — Grand Junction, Colorado (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT07060807)

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Non-small Cell Lung Cancer Phase 3 Interventional 1,000 participants sought

Local Institution - 0500 — Grand Junction, Colorado (1.9 mi) · Sponsor: Bristol-Myers Squibb

See eligibility & contact on ClinicalTrials.gov (NCT06561386)

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT05929768)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04267848)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought

Grand Valley Oncology — Grand Junction, Colorado (1.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT02523014)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought

Colorado West Healthcare System-Grand Valley Oncology ( Site 0165) — Grand Junction, Colorado (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06890884)

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Parkinson's Disease N/A Observational 1,500 participants sought

St. Mary's Hospital and Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: Boston Scientific Corporation

See eligibility & contact on ClinicalTrials.gov (NCT02071134)

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer Phase 3 Interventional 330 participants sought

Colorado West Healthcare System dba Grand Valley Oncology — Grand Junction, Colorado (1.9 mi) · Sponsor: Amgen

See eligibility & contact on ClinicalTrials.gov (NCT07005128)

OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

Breast Cancer, Advanced Breast Cancer Phase 3 Interventional 510 participants sought

Clinical Trial Site — Grand Junction, Colorado (1.9 mi) · Sponsor: Olema Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06016738)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,260 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06931340)

Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia

Staphylococcus Aureus Bacteremia Phase 4 Interventional 2,096 participants sought

St. Mary's Regional Hospital — Grand Junction, Colorado (1.9 mi) · Sponsor: Intermountain Health Care, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07376889)

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Lung Cancer (Diagnosis) N/A Interventional 2,063 participants sought

VA Western Colorado Health Care System — Grand Junction, Colorado (1.9 mi) · Sponsor: bioAffinity Technologies Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07168993)

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Non-small Cell Lung Cancer Phase 3 Interventional 320 participants sought

Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado (1.9 mi) · Sponsor: Canadian Cancer Trials Group

See eligibility & contact on ClinicalTrials.gov (NCT06686771)

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Non-small Cell Lung Cancer (NSCLC) Phase 3 Interventional 614 participants sought

Cancer Centers of Colorado St. Mary's Regional Hospital ( Site 0132) — Grand Junction, Colorado (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06170788)

A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract

Age Related Cataracts Phase 2 Interventional 40 participants sought

ICON Eye Care — Grand Junction, Colorado (1.9 mi) · Sponsor: Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.

See eligibility & contact on ClinicalTrials.gov (NCT07395986)

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Lumbar Spinal Stenosis N/A Observational 8,000 participants sought

Redlands Mesa Surgery Center — Grand Junction, Colorado (1.9 mi) · Sponsor: Stryker Instruments

See eligibility & contact on ClinicalTrials.gov (NCT03072927)

Actively enrolling

Studies you may be able to join near Grand Junction

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Grand Junction

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Primary Care Partners Inc.

★ 3.4

3150 N 12th St, Grand Junction, CO 81506

(970) 256-5211

Website

"I spent one of the worst nights in Delta hospital that I ever had .The bed had half the buttons didn't work and the mattress i had seams like it had …"

— Leroy Foreman, 3★

Western Slope Veterinary Diagnostic Laboratory, CSU

3164 B 1/2 Rd, Grand Junction, CO 81503

(970) 243-0673

Website

Clinical trials in Grand Junction: what's recruiting

The Grand Junction area currently has 51 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Grand Junction, the most active research areas are:

Cancer & Oncology16 studies
Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Grand Junction, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Grand Junction

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Grand Junction participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Grand Junction pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

How do I join a study in Grand Junction, CO?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

What is the difference between a research center and a hospital study in Grand Junction?

Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Grand Junction typically complete one or two studies per year.

Paid clinical trials near Grand Junction

Other metros within reach

Provo, UT127 Lakewood, CO1,598 Thornton, CO1,602 Denver, CO1,598 Salt Lake City, UT1,178 Fort Collins, CO155 Colorado Springs, CO207 Aurora, CO1,565

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Grand Junction Bladder Issues Due To Spinal Cord Injury in Grand Junction All conditions

More of CO

Thornton1,602 Denver1,598 Lakewood1,598 Aurora1,565 Colorado Springs207 Greeley157 Fort Collins155

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts